Skip to main content
SpringerLink
Log in

„Drug-coated-Stent“ bei Patienten mit hohem Blutungsrisiko dem „Bare‑metal‑Stent“ überlegen

Zwei-Jahres-Ergebnisse der LEADERS‑FREE‑Studie

Drug-coated stents superior to bare metal stents in patients with high risk of bleeding

Two-year results of the LEADERS FREE study

  • Journal Club
  • Published:
Der Kardiologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bønaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygård O, Nilsen DW, Kløw NE, Uchto M, Trovik T, Bendz B, Stavnes S, Bjørnerheim R, Larsen AI, Slette M, Steigen T, Jakobsen OJ, Bleie Ø, Fossum E, Hanssen TA, Dahl-Eriksen Ø, Njølstad I, Rasmussen K, Wilsgaard T, Nordrehaug JE, NORSTENT Investigators (2016) Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med 375(13):1242–1252

    Article  PubMed  Google Scholar 

  2. Serruys PW, Chevalier B, Sotomi Y, Cequier A, Carrié D, Piek JJ, Van Boven AJ, Dominici M, Dudek D, McClean D, Helqvist S, Haude M, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Sabaté M, Windecker S, Onuma Y (2016) Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial. Lancet 388(10059):2479–2491

    Article  CAS  PubMed  Google Scholar 

  3. Ariotti S, Adamo M, Costa F, Patialiakas A, Briguori C, Thury A, Colangelo S, Campo G, Tebaldi M, Ungi I, Tondi S, Roffi M, Menozzi A, de Cesare N, Garbo R, Meliga E, Testa L, Gabriel HM, Ferlini M, Vranckx P, Valgimigli M, ZEUS Investigators (2016) Is bare-metal stent implantation still justifiable in high bleeding risk patients undergoing percutaneous coronary intervention?: A pre-specified analysis from the ZEUS trial. JACC Cardiovasc Interv 9(5):426–436

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardioangiologisches Centrum Bethanien (CCB), Im Prüfling 23, 60389, Frankfurt am Main, Deutschland

    H. Eggebrecht

Authors
  1. H. Eggebrecht
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Eggebrecht.

Ethics declarations

Interessenkonflikt

H. Eggebrecht gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eggebrecht, H. „Drug-coated-Stent“ bei Patienten mit hohem Blutungsrisiko dem „Bare‑metal‑Stent“ überlegen. Kardiologe 11, 148–150 (2017). https://doi.org/10.1007/s12181-017-0127-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12181-017-0127-3

Search

Navigation